Ginkgo Bioworks Holdings Inc (DNA)
0.9072
+0.06
(+7.64%)
USD |
NYSE |
Apr 23, 11:16
Ginkgo Bioworks Holdings Price to Book Value: 1.780 for April 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 1.653 |
| April 19, 2024 | 1.697 |
| April 18, 2024 | 1.814 |
| April 17, 2024 | 1.710 |
| April 16, 2024 | 1.792 |
| April 15, 2024 | 1.864 |
| April 12, 2024 | 1.981 |
| April 11, 2024 | 2.060 |
| April 10, 2024 | 2.197 |
| April 09, 2024 | 2.276 |
| April 08, 2024 | 2.178 |
| April 05, 2024 | 2.119 |
| April 04, 2024 | 2.099 |
| April 03, 2024 | 2.138 |
| April 02, 2024 | 2.060 |
| April 01, 2024 | 2.197 |
| March 28, 2024 | 2.276 |
| March 27, 2024 | 2.158 |
| March 26, 2024 | 2.099 |
| March 25, 2024 | 2.138 |
| March 22, 2024 | 2.099 |
| March 21, 2024 | 2.236 |
| March 20, 2024 | 2.256 |
| March 19, 2024 | 2.138 |
| March 18, 2024 | 2.138 |
| Date | Value |
|---|---|
| March 15, 2024 | 2.119 |
| March 14, 2024 | 2.080 |
| March 13, 2024 | 2.295 |
| March 12, 2024 | 2.295 |
| March 11, 2024 | 2.393 |
| March 08, 2024 | 2.393 |
| March 07, 2024 | 2.354 |
| March 06, 2024 | 2.393 |
| March 05, 2024 | 2.256 |
| March 04, 2024 | 2.472 |
| March 01, 2024 | 2.531 |
| February 29, 2024 | 2.982 |
| February 28, 2024 | 2.982 |
| February 27, 2024 | 3.002 |
| February 26, 2024 | 2.746 |
| February 23, 2024 | 2.590 |
| February 22, 2024 | 2.590 |
| February 21, 2024 | 2.353 |
| February 20, 2024 | 2.499 |
| February 16, 2024 | 2.681 |
| February 15, 2024 | 2.827 |
| February 14, 2024 | 2.718 |
| February 13, 2024 | 2.462 |
| February 12, 2024 | 2.754 |
| February 09, 2024 | 2.572 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.432
Minimum
Mar 28 2023
42.75
Maximum
Sep 27 2021
4.337
Average
2.810
Median
Jun 29 2022
Price to Book Value Benchmarks
| Agenus Inc | -- |
| Teladoc Health Inc | 0.9998 |
| Sarepta Therapeutics Inc | 13.06 |
| Ultragenyx Pharmaceutical Inc | 13.51 |
| Apellis Pharmaceuticals Inc | 30.36 |
Price to Book Value Related Metrics
| PS Ratio | 7.016 |
| Price | 0.9072 |
| Earnings Yield | -51.81% |
| Market Cap | 1.953B |